Heineken is trading for 25% less than its February 2020 highs on the back of short-term headwinds brought by Covid-19 pandemic. The business model is outstandin


Recent Purchase: Pepsico

I recently added to my PepsiCo position at $108.15. Shares were yielding nearly 3.8% at the time. This price represents a sub-20x ttm P/E multiple and a ~18.5x


Remy Cointreau: Buying The Coronavirus Correction

Remy Cointreau has lost nearly a third of its value in recent months. This has coincided with a sharp drop-off in Asian sales, which was primarily linked to the


Mannkind Corporation (mnkd) Ceo Michael Castagna On Q3 2019 Results

MannKind Corporation (NASDAQ:MNKD) Q3 2019 Earnings Conference Call November 6, 2019 09:00 ET Company Participants Michael Castagna - CEO Steven Binder - CFO Co


Krystal Biotech: Kb-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease

Krystal Biotech is currently developing KB-103, an off-the-shelf easily applicable gene therapy for rare congenital skin diseases. If approved, KB-103 will be m



MannKind is in better cash flow situation that it has been in the past. CEO vision includes more non-dilutive options than in the past. Leaner operations help i

The Daily Feed

Receive a daily summary of drinks news.

Corby Spirit And Wine Limited (cbydf) Ceo Patrick O’driscoll On Q4 2019

Corby Spirit and Wine Limited (OTCPK:CBYDF) Q4 2019 Results Earnings Conference Call August 21, 2019, 05:00 PM ET Company Participants Patrick O'Driscoll - Pres


Mannkind Corporation (mnkd) Ceo Michael Castagna On Q2 2019 Results

MannKind Corporation (NASDAQ:MNKD) Q2 2019 Earnings Conference Call August 07, 2019 5:00 PM ET Company Participants Michael Castagna - Chief Executive Officer S


Mannkind’s Ceo Castagna Is Failing To Deliver

Marketing Afrezza is a costly endeavor with expenses greatly exceeding revenue. CEO Castagna has mentioned epinephrine and other pipeline molecules several time


Mannkind’s Ceo Castagna Squanders An Opportunity To End Share Price Erosion

During the JMP conference, CEO Castagna discussed at length inhalable insulin Afrezza's attributes while providing virtually no concrete pipeline guidance. Mana

Social Connections